128 related articles for article (PubMed ID: 34190800)
1. Phenotypic and molecular characterization of fluoroquinolone resistant Pseudomonas aeruginosa isolates in Palestine.
Adwan G; Omar G
Braz J Biol; 2021; 82():e239868. PubMed ID: 34190800
[TBL] [Abstract][Full Text] [Related]
2. The role of gyrA and parC mutations in fluoroquinolones-resistant Pseudomonas aeruginosa isolates from Iran.
Nouri R; Ahangarzadeh Rezaee M; Hasani A; Aghazadeh M; Asgharzadeh M
Braz J Microbiol; 2016; 47(4):925-930. PubMed ID: 27522930
[TBL] [Abstract][Full Text] [Related]
3. [Susceptibility of 570 Pseudomonas aeruginosa strains to 11 antimicrobial agents and the mechanism of its resistance to fluoroquinolones].
Lei YC; Wang HB; Sun ZY; Shen ZY
Zhonghua Yi Xue Za Zhi; 2003 Mar; 83(5):403-7. PubMed ID: 12820918
[TBL] [Abstract][Full Text] [Related]
4. Alterations in the GyrA and GyrB subunits of topoisomerase II and the ParC and ParE subunits of topoisomerase IV in ciprofloxacin-resistant clinical isolates of Pseudomonas aeruginosa.
Lee JK; Lee YS; Park YK; Kim BS
Int J Antimicrob Agents; 2005 Apr; 25(4):290-5. PubMed ID: 15784307
[TBL] [Abstract][Full Text] [Related]
5. Mutations in topoisomerase genes of fluoroquinolone-resistant salmonellae in Hong Kong.
Ling JM; Chan EW; Lam AW; Cheng AF
Antimicrob Agents Chemother; 2003 Nov; 47(11):3567-73. PubMed ID: 14576119
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial resistance and novel mutations detected in the gyrA and parC genes of Pseudomonas aeruginosa strains isolated from companion dogs.
Park Y; Oh J; Park S; Sum S; Song W; Chae J; Park H
BMC Vet Res; 2020 Apr; 16(1):111. PubMed ID: 32293442
[TBL] [Abstract][Full Text] [Related]
7. Type II topoisomerase mutations in fluoroquinolone-resistant clinical strains of Pseudomonas aeruginosa isolated in 1998 and 1999: role of target enzyme in mechanism of fluoroquinolone resistance.
Akasaka T; Tanaka M; Yamaguchi A; Sato K
Antimicrob Agents Chemother; 2001 Aug; 45(8):2263-8. PubMed ID: 11451683
[TBL] [Abstract][Full Text] [Related]
8. gyrA and parC mutations in quinolone-resistant clinical isolates of Pseudomonas aeruginosa from Nini Hospital in north Lebanon.
Salma R; Dabboussi F; Kassaa I; Khudary R; Hamze M
J Infect Chemother; 2013 Feb; 19(1):77-81. PubMed ID: 22821356
[TBL] [Abstract][Full Text] [Related]
9. Emergence of a new mutation and its accumulation in the topoisomerase IV gene confers high levels of resistance to fluoroquinolones in Escherichia coli isolates.
Moon DC; Seol SY; Gurung M; Jin JS; Choi CH; Kim J; Lee YC; Cho DT; Lee JC
Int J Antimicrob Agents; 2010 Jan; 35(1):76-9. PubMed ID: 19781915
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of fluoroquinolone resistance and mutations in the gyrA, parC and parE genes of Riemerella anatipestifer isolated from ducks in China.
Zhu D; Zheng M; Xu J; Wang M; Jia R; Chen S; Liu M; Zhao X; Yang Q; Wu Y; Zhang S; Huang J; Liu Y; Zhang L; Yu Y; Pan L; Chen X; Cheng A
BMC Microbiol; 2019 Dec; 19(1):271. PubMed ID: 31795952
[TBL] [Abstract][Full Text] [Related]
11. Fitness of Streptococcus pneumoniae fluoroquinolone-resistant strains with topoisomerase IV recombinant genes.
Balsalobre L; de la Campa AG
Antimicrob Agents Chemother; 2008 Mar; 52(3):822-30. PubMed ID: 18160515
[TBL] [Abstract][Full Text] [Related]
12. Mutations in the gyrA and parC genes and in vitro activities of fluoroquinolones in 114 clinical isolates of Pseudomonas aeruginosa derived from urinary tract infections and their rapid detection by denaturing high-performance liquid chromatography.
Matsumoto M; Shigemura K; Shirakawa T; Nakano Y; Miyake H; Tanaka K; Kinoshita S; Arakawa S; Kawabata M; Fujisawa M
Int J Antimicrob Agents; 2012 Nov; 40(5):440-4. PubMed ID: 22884856
[TBL] [Abstract][Full Text] [Related]
13. Accumulation of mutations in DNA gyrase and topoisomerase IV genes contributes to fluoroquinolone resistance in Vibrio cholerae O139 strains.
Zhou Y; Yu L; Li J; Zhang L; Tong Y; Kan B
Int J Antimicrob Agents; 2013 Jul; 42(1):72-5. PubMed ID: 23643392
[TBL] [Abstract][Full Text] [Related]
14. [Fluoroquinolone resistance mutations in topoisomerase genes of Salmonella typhimurium isolates].
Guo Y; Pei X; Liu X
Wei Sheng Yan Jiu; 2004 Sep; 33(5):591-4. PubMed ID: 15612489
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of plasmid-mediated quinolone resistance and mutations in the gyrase and topoisomerase IV genes in Salmonella isolated from 12 tertiary-care hospitals in Korea.
Jeong HS; Kim JA; Shin JH; Chang CL; Jeong J; Cho JH; Kim MN; Kim S; Kim YR; Lee CH; Lee K; Lee MA; Lee WG; Shin JH; Lee JN
Microb Drug Resist; 2011 Dec; 17(4):551-7. PubMed ID: 21830947
[TBL] [Abstract][Full Text] [Related]
16. Comparison of full gyrA, gyrB, parC and parE gene sequences between all Ureaplasma parvum and Ureaplasma urealyticum serovars to separate true fluoroquinolone antibiotic resistance mutations from non-resistance polymorphism.
Beeton ML; Chalker VJ; Kotecha S; Spiller OB
J Antimicrob Chemother; 2009 Sep; 64(3):529-38. PubMed ID: 19567408
[TBL] [Abstract][Full Text] [Related]
17. Molecular Evaluation of High Fluoroquinolone Resistant Genes in Endemic Cases of Shigellosis, Northeast Part of Karnataka, India.
C P; Desai P; R KC
Ann Glob Health; 2016; 82(5):832-839. PubMed ID: 28283137
[TBL] [Abstract][Full Text] [Related]
18. [Fluoroquinolone resistance determining region mutation in Streptococcus pneumonia isolates].
Zhang FF; Zhao CJ; Wang H
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Dec; 36(12):940-4. PubMed ID: 24503427
[TBL] [Abstract][Full Text] [Related]
19. Gene-Gene Interactions Dictate Ciprofloxacin Resistance in Pseudomonas aeruginosa and Facilitate Prediction of Resistance Phenotype from Genome Sequence Data.
Rehman A; Jeukens J; Levesque RC; Lamont IL
Antimicrob Agents Chemother; 2021 Jun; 65(7):e0269620. PubMed ID: 33875431
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms of quinolone resistance in clinical strains of Pseudomonas aeruginosa.
Jalal S; Wretlind B
Microb Drug Resist; 1998; 4(4):257-61. PubMed ID: 9988043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
